These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7110533

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.
    Fuller RW, Hemrick-Luecke SK, Ornstein PL.
    Neuropharmacology; 1992 Oct; 31(10):1027-32. PubMed ID: 1436384
    [Abstract] [Full Text] [Related]

  • 10. Effect of cysteine on the persistent depletion of brain monoamines by amphetamine, p-chloroamphetamine and MPTP.
    Steranka LR, Rhind AW.
    Eur J Pharmacol; 1987 Jan 13; 133(2):191-7. PubMed ID: 3493165
    [Abstract] [Full Text] [Related]

  • 11. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats.
    Henderson MG, Perry KW, Fuller RW.
    J Pharmacol Exp Ther; 1993 Oct 13; 267(1):417-24. PubMed ID: 8229770
    [Abstract] [Full Text] [Related]

  • 12. Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents.
    Fuller RW, Steranka LR.
    Life Sci; 1985 Jan 21; 36(3):243-7. PubMed ID: 3871244
    [Abstract] [Full Text] [Related]

  • 13. Neurochemical effects of amphetamine metabolites on central dopaminergic and serotonergic systems.
    Matsuda LA, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1989 Dec 21; 251(3):901-8. PubMed ID: 2600821
    [Abstract] [Full Text] [Related]

  • 14. Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.
    Fuller RW, Hemrick-Luecke SK, Snoddy HD.
    J Neural Transm Gen Sect; 1994 Dec 21; 96(3):165-77. PubMed ID: 7826568
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
    Schmidt CJ, Gibb JW.
    Eur J Pharmacol; 1985 Feb 12; 109(1):73-80. PubMed ID: 2581794
    [Abstract] [Full Text] [Related]

  • 18. Nerve terminal degeneration after a single injection of D-amphetamine in iprindole-treated rats: relation to selective long-lasting dopamine depletion.
    Ricaurte GA, Guillery RW, Seiden LS, Schuster CR.
    Brain Res; 1984 Jan 23; 291(2):378-82. PubMed ID: 6697198
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems.
    McMillen BA, Shore PA.
    J Pharm Pharmacol; 1978 Jul 23; 30(7):464-6. PubMed ID: 27622
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.